Clinical relevancePreliminary results suggest that DCE-MRI could be a safe method to stratify PD-L1 hypo/hyperexpression in non-small cell lung cancer, potentially optimizing treatment decisions, given the high cost of immunotherapy. This evidence concerns the gene CD274 and non-small cell lung carcinoma.